SG165168A1 - New adenoviruses, nucleic acids coding therefor and their use - Google Patents

New adenoviruses, nucleic acids coding therefor and their use

Info

Publication number
SG165168A1
SG165168A1 SG200703426-7A SG2007034267A SG165168A1 SG 165168 A1 SG165168 A1 SG 165168A1 SG 2007034267 A SG2007034267 A SG 2007034267A SG 165168 A1 SG165168 A1 SG 165168A1
Authority
SG
Singapore
Prior art keywords
nucleic acids
acids coding
coding therefor
adenoviruses
new
Prior art date
Application number
SG200703426-7A
Other languages
English (en)
Inventor
Per Sonne Holm
Original Assignee
Sonne Holm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2003/005583 external-priority patent/WO2003099859A2/fr
Application filed by Sonne Holm filed Critical Sonne Holm
Publication of SG165168A1 publication Critical patent/SG165168A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/763—Herpes virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG200703426-7A 2002-10-15 2003-10-15 New adenoviruses, nucleic acids coding therefor and their use SG165168A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10248039 2002-10-15
DE10322530 2003-05-19
DE10324085 2003-05-27
PCT/EP2003/005583 WO2003099859A2 (fr) 2002-05-27 2003-05-27 Nouvelle utilisation d'adenovirus et acides nucleiques codant pour ces derniers

Publications (1)

Publication Number Publication Date
SG165168A1 true SG165168A1 (en) 2010-10-28

Family

ID=32314683

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200703426-7A SG165168A1 (en) 2002-10-15 2003-10-15 New adenoviruses, nucleic acids coding therefor and their use

Country Status (9)

Country Link
US (1) US8951772B2 (fr)
EP (1) EP1554375B1 (fr)
AU (1) AU2010257327C1 (fr)
DK (1) DK1554375T3 (fr)
MX (1) MXPA05004074A (fr)
PL (1) PL219321B1 (fr)
SG (1) SG165168A1 (fr)
WO (1) WO2004035616A2 (fr)
ZA (1) ZA200502680B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003222427B8 (en) 2000-11-17 2010-04-29 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same
US8071740B2 (en) 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
EP2277887A3 (fr) 2001-10-19 2011-02-16 Vascular Biogenics Ltd. Constructions de polynucléotides, compositions pharmaceutiques et procédés pour la régulation négative ciblée de l'angiogenèse et du traitement contre le cancer.
EP1506021B1 (fr) 2002-05-27 2019-05-01 Per Sonne Holm Utilisation d'adenovirus et acides nucleiques codant pour ces derniers
EP1689445B1 (fr) 2003-11-14 2015-02-25 Per Sonne Holm Nouvelle utilisation d'adenovirus et d'acides nucleiques les codant
EP1830864A2 (fr) * 2004-12-31 2007-09-12 Per Sonne Holm Adenovirus a region e1 absente et leur utilisation
CA2592699C (fr) * 2004-12-31 2023-02-21 Per Sonne Holm Methode d'annulation de la multiresistance dans des cellules animales
KR100747646B1 (ko) * 2005-02-25 2007-08-08 연세대학교 산학협력단 데코린 유전자를 포함하는 유전자 전달 시스템 및 이를 포함하는 약제학적 항종양 조성물
WO2012022496A2 (fr) 2010-08-19 2012-02-23 Per Sonne Holm Procédé pour tuer des cellules souches tumorales
CN112533620A (zh) * 2018-03-05 2021-03-19 慕尼黑工业大学临床教学中心 通过溶瘤腺病毒和cdk4/6抑制剂的组合治疗肿瘤
KR20210030941A (ko) * 2018-06-25 2021-03-18 오스페달레 산 라파엘 에스.알.엘. 유전자 요법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046779A1 (fr) * 1997-04-14 1998-10-22 Genzyme Corporation Vecteurs adenoviraux comprenant une region e4 modifiee mais retenant e4orf3
WO2001070951A2 (fr) * 2000-03-23 2001-09-27 Max-Delbrück-Centrum für Molekulare Medizin Moyen de diagnostic et de therapie de maladies virales
WO2002053711A2 (fr) * 2000-12-28 2002-07-11 Per Sonne Holm Systemes de vecteurs adenoviraux et leurs utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998205A (en) * 1994-11-28 1999-12-07 Genetic Therapy, Inc. Vectors for tissue-specific replication
AU2002235141A1 (en) * 2000-11-27 2002-06-03 Geron Corporation Glycosyltransferase vectors for treating cancer
US20030095989A1 (en) * 2000-12-18 2003-05-22 Irving John M. Chimeric cytolytic viruses for cancer treatment
US20030138405A1 (en) * 2001-04-17 2003-07-24 Juan Fueyo Conditionally replicative adenovirus to target the Rb and Rb-related pathways

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046779A1 (fr) * 1997-04-14 1998-10-22 Genzyme Corporation Vecteurs adenoviraux comprenant une region e4 modifiee mais retenant e4orf3
WO2001070951A2 (fr) * 2000-03-23 2001-09-27 Max-Delbrück-Centrum für Molekulare Medizin Moyen de diagnostic et de therapie de maladies virales
WO2002053711A2 (fr) * 2000-12-28 2002-07-11 Per Sonne Holm Systemes de vecteurs adenoviraux et leurs utilisations

Also Published As

Publication number Publication date
PL376573A1 (pl) 2006-01-09
DK1554375T3 (en) 2018-12-17
WO2004035616A2 (fr) 2004-04-29
WO2004035616A3 (fr) 2004-05-27
AU2010257327B2 (en) 2011-09-29
PL219321B1 (pl) 2015-04-30
MXPA05004074A (es) 2005-09-20
US8951772B2 (en) 2015-02-10
EP1554375A2 (fr) 2005-07-20
EP1554375B1 (fr) 2018-08-22
US20060057113A1 (en) 2006-03-16
AU2010257327A1 (en) 2011-01-13
ZA200502680B (en) 2005-11-30
AU2010257327C1 (en) 2012-02-16

Similar Documents

Publication Publication Date Title
DE69916591T2 (de) Hochzähe, hochfeste amorphe zirkoniumlegierung
SG165168A1 (en) New adenoviruses, nucleic acids coding therefor and their use
AU2003216273A8 (en) Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
EP1218392A4 (fr) Nouveaux genes codant pour des proteines a usages previsionnel, diagnostique therapeutique et autres
PE20399A1 (es) Muteina ob
EP1074622A4 (fr) Nouveau polypeptide, adnc le codant et son utilisation
AP2006003504A0 (en) Outer surface proteins, their genes, and their use.
DE69930370D1 (de) Testisspezifische, menschliche proteinase, svph1-8
EP1104771A4 (fr) NOUVEAU POLYPEPTIDE, ADNc LE CODANT ET SON UTILISATION
AU8953401A (en) A novel polypeptide, a human protein 16.83 ftsh and the polynucleotide encoding the polypeptide
AU2769101A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
WO2001055209A3 (fr) Nouvelle septine humaine et utilisations
NO20024029D0 (no) Nytt protein og gen som koder for proteinet
AU8948301A (en) A novel polypeptide, a human splicing protein 10.56 and the polynucleotide encoding the polypeptide
DZ2803A1 (fr) Polypeptide de la protéine c humaine.
AU8948801A (en) A novel polypeptide, a human transformer-2-beta protein 29.15 and the polynucleotide encoding the polypeptide
ZA200409367B (en) Novel use of adenoviruses and nucleic acids coding therefore.
AU9364501A (en) A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide
AU1660000A (en) The polypeptide dream, used as CA2+ions-dependent transcriptional regulator and its gene coding therefor
AU9362301A (en) A novel polypeptide, a human apoptosis relative protein 9.46 and the polynucleotide encoding the polypeptide
AU8951501A (en) A novel polypeptide, a human tumor suppressor factor 11.77 and the polynucleotide encoding the polypeptide
AU2003227428A8 (en) Novel proteins and dnas encoding the same
AU1378701A (en) A novel polypeptide, a human apoptosis associated protein 12 and the polynucleotide encoding the polypeptide
AU8954201A (en) A novel polypeptide, a human phosphatase protein 9.68 and the polynucleotide encoding the polypeptide
AU2002212051A1 (en) A novel polypeptide, a human big protein 9.24 and the polynucleotide encoding the polypeptide